Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Zoonoses Public Health ; 65(4): 425-430, 2018 06.
Article in English | MEDLINE | ID: mdl-29430859

ABSTRACT

The canine variant of the rabies virus has been eliminated in the United States. Among the public and many healthcare providers, however, dog bites are still associated with risk for rabies transmission. This study examined the risk of rabies in biting dogs and the use of rabies post-exposure prophylaxis (rPEP) for dog bite victims in Tennessee. The study included a retrospective analysis of laboratory testing requisitions for dogs from 2002 to 2016, collection of clinical data on confirmed rabies-positive dogs from 2008 to 2016 and analysis of hospital discharge data for rPEP from 2007 to 2014. Among dogs submitted for rabies testing, those having a recent history of biting were significantly less likely to test positive for rabies than dogs with no reported bite (OR = 0.01; 95% CI [0.003-0.04]). The most common clinical signs reported among rabies-positive dogs were anorexia, dysphagia, ataxia, limb paresis or paralysis, and lethargy; aggressiveness was uncommon. Among hospital patients with an animal-related injury who received rPEP, more than half (52%) presented with dog bites. These data show that laboratory submissions for rabies testing and prescriptions for rPEP do not reflect the epidemiology of rabies in Tennessee. Education and outreach targeting the public and healthcare providers should emphasize the animal species and situations associated with a greater risk for rabies transmission, such as bites from rabies reservoir species or animals exhibiting signs of neurologic disease.


Subject(s)
Bites and Stings/veterinary , Disease Reservoirs/veterinary , Dog Diseases/transmission , Post-Exposure Prophylaxis/statistics & numerical data , Rabies/veterinary , Animals , Bites and Stings/epidemiology , Bites and Stings/virology , Cat Diseases/epidemiology , Cat Diseases/transmission , Cat Diseases/virology , Cats , Disease Reservoirs/virology , Dog Diseases/epidemiology , Dog Diseases/virology , Dogs , Health Personnel/education , Humans , Public Health/economics , Public Health/education , Rabies/epidemiology , Rabies/prevention & control , Rabies/transmission , Rabies Vaccines/administration & dosage , Rabies virus/isolation & purification , Retrospective Studies , Risk Factors , Tennessee/epidemiology
2.
J Food Prot ; 78(1): 187-95, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25581195

ABSTRACT

Surveillance data indicate that handling of food by an ill worker is a cause of almost half of all restaurant-related outbreaks. The U.S. Food and Drug Administration (FDA) Food Code contains recommendations for food service establishments, including restaurants, aimed at reducing the frequency with which food workers work while ill. However, few data exist on the extent to which restaurants have implemented FDA recommendations. The Centers for Disease Control and Prevention's Environmental Health Specialists Network (EHS-Net) conducted a study on the topic of ill food workers in restaurants. We interviewed restaurant managers (n = 426) in nine EHS-Net sites. We found that many restaurant policies concerning ill food workers do not follow FDA recommendations. For example, one-third of the restaurants' policies did not specifically address the circumstances under which ill food workers should be excluded from work (i.e., not be allowed to work). We also found that, in many restaurants, managers are not actively involved in decisions about whether ill food workers should work. Additionally, almost 70% of managers said they had worked while ill; 10% said they had worked while having nausea or "stomach flu," possible symptoms of foodborne illness. When asked why they had worked when ill, a third of the managers said they felt obligated to work or their strong work ethic compelled them to work. Other reasons cited were that the restaurant was understaffed or no one was available to replace them (26%), they felt that their symptoms were mild or not contagious (19%), they had special managerial responsibilities that no one else could fulfill (11%), there was non-food handling work they could do (7%), and they would not get paid if they did not work or the restaurant had no sick leave policy (5%). Data from this study can inform future research and help policy makers target interventions designed to reduce the frequency with which food workers work while ill.


Subject(s)
Food Handling/standards , Occupational Health/standards , Personnel Management/standards , Restaurants/standards , Adult , Centers for Disease Control and Prevention, U.S. , Disease Outbreaks , Food Contamination/analysis , Foodborne Diseases/epidemiology , Foodborne Diseases/etiology , Humans , Middle Aged , Sick Leave , United States , United States Food and Drug Administration , Workforce
3.
Zoonoses Public Health ; 58(7): 489-92, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21824352

ABSTRACT

Brucellosis is a common zoonotic disease worldwide; however, few cases are reported in the US. Brucella melitensis infections are primarily acquired via consumption of high-risk foods or travel to endemic areas. We describe a case of B. melitensis infection in a Tennessee soldier following deployment in Iraq. Initial symptoms included knee and back pain. Culture of an aspirate of the left sacroiliac joint yielded B. melitensis. Genetic analysis indicated that this isolate came from the Middle East. Investigation of laboratory workers identified risky exposures and positive serology prompting post-exposure prophylaxis. Military personnel and other travellers should be advised to reduce risk regarding food consumption and animal contact in endemic areas. Additionally, medical providers should remain vigilant for non-endemic zoonoses among recent travellers.


Subject(s)
Brucella melitensis , Brucellosis/epidemiology , Brucellosis/etiology , Iraq War, 2003-2011 , Military Personnel , Animals , Anti-Bacterial Agents/therapeutic use , Brucellosis/drug therapy , Brucellosis/microbiology , Humans , Male , Young Adult
4.
Pharmacoepidemiol Drug Saf ; 18(4): 344-8, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19242954

ABSTRACT

PURPOSE: To investigate cases of febrile illnesses in patients who received propofol for sedation during gastrointestinal endoscopy. METHODS: Active case finding for patients who underwent endoscopy between 1 April and 30 May 2007 and suffered unexplained fever, chills, or myalgia within 48 hour after the procedure. We reviewed medications and clinical practices to find factors associated with the reactions. RESULTS: Seventy-four cases at eight facilities in five states were identified yielding a rate of 36 reactions per 1000 procedures, compared with a baseline rate of 0.6 per 1000. The majority of patients experienced self-limited fever (89.2%), chills (73.0%), or myalgia (63.5%). Blood samples from five patients were collected for culture; no organisms grew. All health care facilities that reported cases and fully participated in the investigation (n = 7) had received a common lot of propofol just before recognition of the first case. Bacterial endotoxin and sterility testing on unopened vials from this lot of propofol showed no abnormalities. Cases terminated after facilities stopped using the associated lot of propofol. CONCLUSIONS: We found a temporal association between a particular lot of propofol and an outbreak of febrile illnesses at several healthcare facilities performing endoscopy. When propofol is used to sedate patients for endoscopy, fever is a rare outcome and healthcare professionals should investigate clusters of these reactions. Post-procedure surveillance is important to identify possible medication reactions.


Subject(s)
Endoscopy, Gastrointestinal , Fever/chemically induced , Hypnotics and Sedatives/adverse effects , Propofol/adverse effects , Adverse Drug Reaction Reporting Systems , Chills/chemically induced , Drug Labeling , Humans , Muscular Diseases/chemically induced , Quality Control , Syndrome , Time Factors , United States , United States Food and Drug Administration
5.
J Bone Miner Res ; 16(3): 501-10, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11277268

ABSTRACT

Previously, we showed that exposure of human osteoblasts to titanium particles stimulates protein tyrosine phosphorylation (PTP), activates the transcription factor nuclear factor kappaB (NF-kappaB), and causes an approximately 50% decrease in the steady-state messenger RNA (mRNA) level of procollagen alpha1[I]. In this study, we identify three NF-kappaB binding sites within the human procollagen alpha1[I] gene promoter, show that titanium particles stimulate their binding of the NF-kappaB subunits Rel A (p65) and NF-kappaB1 (p50), and find NF-kappaB activation correlates with collagen gene suppression by titanium particles in osteoblasts. Protein tyrosine kinase (PTK) inhibitors, which significantly reduce the suppressive effect of titanium particles on collagen gene expression, inhibited NF-kappaB binding activity showing that titanium particle stimulation of PTK signals in osteoblasts are critical for both NF-kappaB activation and collagen gene expression. The antioxidant pyrrolidine dithiocarbamate (PDTC), which also inhibits the titanium particle suppression of collagen, abrogated the titanium particle activation of NF-kappaB, suggesting the involvement of redox signals in NF-kappaB-mediated collagen gene expression. The RNA polymerase II inhibitor actinomycin D (Act D) decreased procollagen alpha1[I] mRNA expression and effectively blocked the titanium-induced suppressive effect, suggesting that titanium particles activate a cascade of signals in osteoblasts, which result in a suppression of procollagen alpha1[I] mRNA. Collectively, these results show that titanium particles can activate NF-kappaB signaling in osteoblasts and suggest that NF-kappaB binding to the collagen gene promoter has a functional role in the down-regulation of procollagen alpha1[I] gene transcription.


Subject(s)
I-kappa B Proteins , NF-kappa B/metabolism , Procollagen/drug effects , Procollagen/genetics , Titanium/pharmacology , Binding Sites , Cytokines/pharmacology , DNA-Binding Proteins/metabolism , Dinoprostone/pharmacology , Down-Regulation , Humans , Indomethacin/pharmacology , NF-KappaB Inhibitor alpha , NF-kappa B/genetics , Osteoblasts/metabolism , Osteosarcoma , Procollagen/metabolism , Promoter Regions, Genetic , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Signal Transduction , Transcription Factor RelA , Transcription, Genetic , Transfection , Tumor Cells, Cultured
6.
J Immunol ; 163(5): 2816-20, 1999 Sep 01.
Article in English | MEDLINE | ID: mdl-10453026

ABSTRACT

Neutrophil infiltration of the airways is a common finding in respiratory syncytial virus (RSV) bronchiolitis. Neutrophil-derived chemokines and neutrophil granule contents can cause further inflammation, hyperresponsiveness, and damage of the airways. In this study, peripheral blood neutrophils incubated with RSV (multiplicity of infection (MOI) = 10) induced IL-8, macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and myeloperoxidase (MPO) release. In contrast, LPS induced only chemokine but not MPO release. RSV-induced chemokine and MPO release was noncytotoxic as assessed by trypan blue exclusion. The mechanism of RSV-induced chemokine release was shown to be transcription dependent since cytokine mRNA synthesis was increased with RSV stimulation and the process was inhibited by actinomycin-D. In addition, the effect of dexamethasone (dex) on mediator release was also studied. Dex significantly inhibited chemokine release but did not inhibit MPO release. The mechanism of inhibition of the release of these chemokines is probably posttranscriptional since the mRNA synthesis was not inhibited by dex. We conclude that the release of chemokines (IL-8, MIP-1alpha, MIP-1beta) and granule enzymes (MPO) by RSV-stimulated neutrophils may contribute to the pulmonary pathology in RSV bronchiolitis. These in vitro findings showing that dex failed to consistently inhibit all the RSV-induced release of neutrophil inflammatory mediators may explain the variable efficacy of corticosteroids in the treatment of RSV bronchiolitis.


Subject(s)
Cell Degranulation/immunology , Chemokines/metabolism , Neutrophils/physiology , Neutrophils/virology , Respiratory Syncytial Virus, Human/immunology , Adult , Chemokines/antagonists & inhibitors , Chemokines/biosynthesis , Chemokines/genetics , Cytotoxicity, Immunologic/immunology , Dexamethasone/pharmacology , Humans , Immunosuppressive Agents/pharmacology , Neutrophils/immunology , Neutrophils/metabolism , RNA, Messenger/biosynthesis , Respiratory Syncytial Virus, Human/physiology , Time Factors
7.
J Leukoc Biol ; 65(3): 291-8, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10080530

ABSTRACT

The promoters of the IL-8, MCP-1, and RANTES genes contain binding sites for the redox-responsive transcription factors AP-1 and NF-kappaB, which have been shown to be important for their expression. In this overview, we present evidence from our laboratories that the stimulus-specific regulation of these chemokines by the reactive oxidant H2O2, the proinflammatory cytokine TNF-alpha, and respiratory syncytial virus (RSV) is mediated in a cell type-specific manner involving different patterns of AP-1 and NF-kappaB binding activity. Our results demonstrate that H2O2 induction of IL-8 gene expression is linked with the selective binding of AP-1 to the IL-8 promoter, whereas TNF-alpha and RSV induction of IL-8 correlates with the activation of NF-kappaB binding. We propose that the differential activation and binding of inducible transcription factors to the promoter regions of chemokine genes provides a critical regulatory mechanism by which the CXC and CC chemokines can be selectively expressed in a cell type-specific and stimulus-specific manner. Such a regulatory mechanism of differential chemokine expression could critically influence the site-specific recruitment of distinct subsets of leukocytes to sites of inflammation and injury.


Subject(s)
Chemokines/genetics , Gene Expression Regulation , NF-kappa B/genetics , Transcription Factor AP-1/genetics , Animals , Chemokines/biosynthesis , Humans , Oxidation-Reduction , Promoter Regions, Genetic , Transcriptional Activation
8.
Proc Natl Acad Sci U S A ; 95(11): 6061-6, 1998 May 26.
Article in English | MEDLINE | ID: mdl-9600917

ABSTRACT

Leptin is an adipocyte-derived cytokine that regulates food intake and body weight via interaction with its Ob receptor (ObR). Serum leptin levels are chronically elevated in obese humans, suggesting that obesity may be associated with leptin resistance and the inability to generate an adequate ObR response. Evidence suggests that transcriptional activation of target genes by STAT3 (signal transducer and activator of transcription) in the hypothalamus is a critical pathway that mediates leptin's action. Herein we report that activation of ObR induces the tyrosine phosphorylation of the tyrosine phosphatase SH2-containing phosphatase 2 (SHP-2) and demonstrate that Tyr986 within the ObR cytoplasmic domain is essential to mediate phosphorylation of SHP-2 and binding of SHP-2 to ObR. Surprisingly, mutation of Tyr986 to Phe, which abrogates SHP-2 phosphorylation and binding to the receptor, dramatically increases gene induction mediated by STAT3. Our findings indicate that SHP-2 is a negative regulator of STAT3-mediated gene induction after activation of ObR and raise the possibility that blocking the interaction of SHP-2 with ObR could overcome leptin resistance by boosting leptin's weight-reducing effects in obese individuals.


Subject(s)
Carrier Proteins/metabolism , DNA-Binding Proteins/metabolism , Protein Tyrosine Phosphatases/metabolism , Proteins/metabolism , Receptors, Cell Surface , Signal Transduction , Trans-Activators/metabolism , Animals , COS Cells , Carrier Proteins/genetics , Humans , Intracellular Signaling Peptides and Proteins , Leptin , Mutation , Obesity/metabolism , Phosphorylation , Protein Phosphatase 2 , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , Protein Tyrosine Phosphatase, Non-Receptor Type 6 , Receptors, Cytokine/genetics , Receptors, Cytokine/metabolism , Receptors, Leptin , SH2 Domain-Containing Protein Tyrosine Phosphatases , STAT3 Transcription Factor , Transfection , src Homology Domains
10.
Mol Biochem Parasitol ; 76(1-2): 115-23, 1996.
Article in English | MEDLINE | ID: mdl-8920000

ABSTRACT

Linearized free maxicircle DNA, present in detergent lysates of Crithidia fasciculata mitochondria, was thought to be a replication intermediate formed during rolling circle replication of maxicircle DNA. Gel electrophoresis of the linearized free maxicircles indicated that they were slightly larger than the maxicircle genome, raising the possibility of the presence of terminal repetitions (Hajduk, S.L., Klein, V.A. and Englund, P.T. (1984) Cell 36, 483-492). We recently found, however, that maxicircles replicate by a theta-mechanism, and not as rolling circles (Carpenter, L.R. and Englund, P.T. (1995) Mol. Cell Biol. 15, 6794-6803). Given that theta-replication does not easily explain the presence of linearized free maxicircles, we investigated alternative explanations for their existence. We present evidence that this DNA species results from the double-strand cleavage of maxicircles due to detergent denaturation of intracellular topoisomerase II cleavable complexes. As expected for a topoisomerase II cleavage product, the linearized free maxicircle DNA is covalently bound to protein at both 5' ends. In addition, the slightly larger apparent size of linearized free maxicircle DNA or maxicircles linearized by a restriction enzyme can be explained by anomalous electrophoretic migration during conventional or pulsed-field agarose gel electrophoresis. This anomalous migration is presumably due to bends or other unusual structures in the DNA.


Subject(s)
Crithidia fasciculata/genetics , DNA Topoisomerases, Type II/metabolism , DNA, Circular/metabolism , DNA, Mitochondrial/chemistry , DNA, Protozoan/chemistry , Animals , Blotting, Southern , DNA Replication , DNA, Circular/chemistry , DNA, Circular/isolation & purification , Electrophoresis, Gel, Pulsed-Field
11.
Mol Cell Biol ; 15(12): 6794-803, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8524245

ABSTRACT

Kinetoplast DNA, the mitochondrial DNA of trypanosomatids, is composed of several thousand minicircles and a few dozen maxicircles, all of which are topologically interlocked in a giant network. We have studied the replication of maxicircle DNA, using electron microscopy to analyze replication intermediates from both Crithidia fasciculata and Trypanosoma brucei. Replication intermediates were stabilized against branch migration by introducing DNA interstrand cross-links in vivo with 4,5',8-trimethylpsoralen and UV radiation. Electron microscopy of individual maxicircles resulting from a topoisomerase II decatenation of kinetoplast DNA networks revealed intact maxicircle theta structures. Analysis of maxicircle DNA linearized by restriction enzyme cleavage revealed branched replication intermediates derived from theta structures. Measurements of the linearized branched molecules in both parasites indicate that replication initiates in the variable region (a noncoding segment characterized by repetitive sequences) and proceeds unidirectionally, clockwise on the standard map.


Subject(s)
Crithidia fasciculata/genetics , DNA Replication , DNA, Kinetoplast/biosynthesis , Trypanosoma brucei brucei/genetics , Animals , Base Sequence , Crithidia fasciculata/metabolism , Cross-Linking Reagents , DNA Topoisomerases, Type II/metabolism , DNA, Kinetoplast/isolation & purification , DNA, Kinetoplast/ultrastructure , Microscopy, Electron , Molecular Sequence Data , Restriction Mapping , Species Specificity , Trioxsalen/pharmacology , Trypanosoma brucei brucei/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...